Skip to main content
  • €1.84 billion
    Total budget of Global Health EDCTP3
  • €418 million
    Funding for 92 projects with clinical trials and scientific studies
  • €20 million
    Funding for 17 projects that strengthen clinical research capacity in sub-Saharan Africa
  • 49 members of EDCTP Association
    33 African and 16 European countries
  • 406 participating entities
    from 64 countries
  • 33 SMEs
    participating in projects

Our projects

Global Health EDCTP3-funded MOVIE-TRACE project logo
  • In progress
  • Emerging or re-emerging infectious diseases
Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.
Global Health EDCTP3-funded EMINENCE project logo
  • In progress
  • Neglected infectious diseases
Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...
Global Health EDCTP3-funded ENABLE project logo
  • In progress
  • HIV/AIDS
Advancing monoclonal antibodies to treat HIV in infantsThe ENABLE project is assessing whether broadly neutralising antibodies could make the HIV virus undetectable in young infants.
Global Health EDCTP3-funded DIDIDI project logo
  • In progress
  • Neglected infectious diseases
Our overall objective is to integrate our consortium’s individual skills, capacity and innovations into advanced, low-cost and deployable digital dashboards and diagnostics to understand how...
Global Health EDCTP3-funded PANGenS project logo
  • In progress
  • Tuberculosis
  • Malaria
  • Cross-disease or disease unspecific
Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...
Global Health EDCTP3-funded MpoxVax AFRIVAC project logo
  • In progress
  • Emerging or re-emerging infectious diseases
The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and over 1,000 deaths, with women accounting for more...
Global Health EDCTP3-funded IVM-KIDS project logo
  • In progress
  • Neglected infectious diseases
Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...
Global Health EDCTP3-funded FAME project logo
  • In progress
  • Neglected infectious diseases
Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).

Our community speaks

  • ‘My message to any young researcher that's considering applying to EDCTP is: do it!’ 

    Catherine Hankins, Senior Fellow at the Amsterdam Institute for Global Health & Development 

  • ‘This programme facilitates collaboration between North and South and invests in innovation and development of the next generation.’

    John Gyapong, Vice-chairperson of the Global Health EDCTP3 Scientific Committee

  • ‘Global Health EDCTP3 is unique in addressing the gaps: strengthening the capacity and the innovation components that are essential for the developing countries.’

    Eleni Aklilu, Professor of Tropical Pharmacology

Newsletter

Our newsletter provides the latest news about Global Health EDCTP3, projects updates, newly signed grants, recent publications as well as upcoming events.

Participating countries in Global Health EDCTP3 projects